Russell Barrans, Chief Commercial Officer at Evofem Biosciences, Inc. (EVFM), bought 4,000 shares at $2.71 ($9K) on 2020-09-10, disclosed to the SEC on 2020-09-11.
Open-market purchase of $9k EVFM by Chief Commercial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.71 | 1,000 | $3K | 30.3% |
| 2 | $2.08 | 3,000 | $6K | 69.7% |
| Total | $2.24 avg | 4,000 | $9K | 100% |
| Filing → |
| EVFM | SELL | 2020-01-21 | $10K | — | Filing → |
| EVFM | BUY | 2018-11-26 | $990 | — | Filing → |
| EVFM | BUY | 2018-08-13 | $7K | — | Filing → |